Seeking Answers to Reach Best Outcomes
Nationwide Children’s is passionate about making a difference in the lives of children not only here in Columbus, Ohio, but across the country and around the world. Investments in our research have produced remarkable advances that are improving outcomes for children everywhere.
Providing Better Health Care for All Children
Our research translates to real-world solutions that benefit children everywhere. Learn how our research – and the funding that supports it – improves the lives of children facing life-threatening health conditions.
Children & Research
Learn how our research benefits children and their families, and how you can participate.
Learn More
Creating Life-Changing Therapies
Gideon Griffiths is the first child at Nationwide Children's to receive a gene therapy for Duchenne muscular dystrophy following the 2023 approval by the FDA. This therapy, and another gene therapy for spinal muscular atrophy, were developed at Nationwide Children's. They are two of the first eight gene therapies ever approved by the FDA.
